Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: A phase IIb trial

  • Stefan Zeuzem
  • , Thomas Berg
  • , Edward Gane
  • , Peter Ferenci
  • , Graham R. Foster
  • , Michael W. Fried
  • , Christophe Hezode
  • , Gideon M. Hirschfield
  • , Ira Jacobson
  • , Igor Nikitin
  • , Paul J. Pockros
  • , Fred Poordad
  • , Jane Scott
  • , Oliver Lenz
  • , Monika Peeters
  • , Vanitha Sekar
  • , Goedele De Smedt
  • , Rekha Sinha
  • , Maria Beumont-Mauviel

Producción científica: Articlerevisión exhaustiva

202 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: A phase IIb trial'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science